PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 63 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,810 | -31.3% | 70,165 | 0.0% | 0.00% | – |
| Q2 2023 | $315,743 | +61.5% | 70,165 | +104.6% | 0.00% | – |
| Q1 2023 | $195,499 | +2.3% | 34,298 | 0.0% | 0.00% | – |
| Q4 2022 | $191,135 | -14.5% | 34,298 | +0.1% | 0.00% | – |
| Q3 2022 | $223,500 | +25.9% | 34,267 | 0.0% | 0.00% | – |
| Q2 2022 | $177,538 | -25.5% | 34,267 | 0.0% | 0.00% | – |
| Q1 2022 | $238,445 | -0.2% | 34,267 | +521.2% | 0.00% | – |
| Q1 2021 | $239,000 | -36.8% | 5,516 | +4.3% | 0.00% | – |
| Q4 2020 | $378,000 | – | 5,289 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $287,436,000 | 2.91% |
| Baker Brothers Advisors | 10,123,824 | $289,845,000 | 1.27% |
| Logos Global Management LP | 400,000 | $11,452,000 | 0.96% |
| Rock Springs Capital Management LP | 382,359 | $10,947,000 | 0.22% |
| HHLR ADVISORS, LTD. | 583,333 | $16,701,000 | 0.17% |
| Virtus ETF Advisers LLC | 6,622 | $190,000 | 0.08% |
| Jump Financial, LLC | 13,700 | $392,000 | 0.04% |
| ARS Investment Partners, LLC | 7,400 | $212,000 | 0.02% |
| FEDERATED HERMES, INC. | 336,100 | $9,623,000 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 1,287,735 | $36,867,853,000 | 0.02% |